Guardant Health
GH
#1540
Rank
$13.48 B
Marketcap
$103.82
Share price
1.76%
Change (1 day)
185.44%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -$3.21

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -$3.21. In 2024 the company made an earnings per share (EPS) of -$3.56 an increase over its 2023 EPS that were of -$4.28.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$3.21-9.83%
2024-$3.56-16.82%
2023-$4.28-33.13%
2022-$6.4060%
2021-$4.0055.04%
2020-$2.58207.14%
2019-$0.84-19.81%
2018-$1.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
-$2.14-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-$4.81 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA